Eurofins-Cerep SA

ALECR.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALECR.PA stands at 89.8M. In comparison, BIM.PA has a market cap of 14B. Regarding current trading prices, ALECR.PA is priced at €17,800.00, while BIM.PA trades at €119.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALECR.PA currently has a P/E ratio of 12.55, whereas BIM.PA's P/E ratio is 32.72. In terms of profitability, ALECR.PA's ROE is +0.10%, compared to BIM.PA's ROE of +0.11%. Regarding short-term risk, ALECR.PA is less volatile compared to BIM.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALECR.PA.

ALECR.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALECR.PA stands at 89.8M. In comparison, ERF.PA has a market cap of 11.1B. Regarding current trading prices, ALECR.PA is priced at €17,800.00, while ERF.PA trades at €63.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALECR.PA currently has a P/E ratio of 12.55, whereas ERF.PA's P/E ratio is 30.32. In terms of profitability, ALECR.PA's ROE is +0.10%, compared to ERF.PA's ROE of +0.05%. Regarding short-term risk, ALECR.PA is less volatile compared to ERF.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALECR.PA.

ALECR.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALECR.PA stands at 89.8M. In comparison, LBIRD.PA has a market cap of 409.4M. Regarding current trading prices, ALECR.PA is priced at €17,800.00, while LBIRD.PA trades at €18.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALECR.PA currently has a P/E ratio of 12.55, whereas LBIRD.PA's P/E ratio is 71.54. In terms of profitability, ALECR.PA's ROE is +0.10%, compared to LBIRD.PA's ROE of +0.03%. Regarding short-term risk, ALECR.PA is less volatile compared to LBIRD.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALECR.PA.

ALECR.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALECR.PA stands at 89.8M. In comparison, MDXH.BR has a market cap of 85.6M. Regarding current trading prices, ALECR.PA is priced at €17,800.00, while MDXH.BR trades at €3.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALECR.PA currently has a P/E ratio of 12.55, whereas MDXH.BR's P/E ratio is -1.58. In terms of profitability, ALECR.PA's ROE is +0.10%, compared to MDXH.BR's ROE of -1.79%. Regarding short-term risk, ALECR.PA is less volatile compared to MDXH.BR. This indicates potentially lower risk in terms of short-term price fluctuations for ALECR.PA.

ALECR.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALECR.PA stands at 89.8M. In comparison, BCART.BR has a market cap of 27.2M. Regarding current trading prices, ALECR.PA is priced at €17,800.00, while BCART.BR trades at €0.29.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALECR.PA currently has a P/E ratio of 12.55, whereas BCART.BR's P/E ratio is -0.32. In terms of profitability, ALECR.PA's ROE is +0.10%, compared to BCART.BR's ROE of +2.04%. Regarding short-term risk, ALECR.PA is less volatile compared to BCART.BR. This indicates potentially lower risk in terms of short-term price fluctuations for ALECR.PA.

ALECR.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALECR.PA stands at 89.8M. In comparison, ALBIO.PA has a market cap of 22.2M. Regarding current trading prices, ALECR.PA is priced at €17,800.00, while ALBIO.PA trades at €1.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALECR.PA currently has a P/E ratio of 12.55, whereas ALBIO.PA's P/E ratio is -0.37. In terms of profitability, ALECR.PA's ROE is +0.10%, compared to ALBIO.PA's ROE of -0.38%. Regarding short-term risk, ALECR.PA is less volatile compared to ALBIO.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALECR.PA.

ALECR.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALECR.PA stands at 89.8M. In comparison, ALPRE.PA has a market cap of 13.4M. Regarding current trading prices, ALECR.PA is priced at €17,800.00, while ALPRE.PA trades at €3.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALECR.PA currently has a P/E ratio of 12.55, whereas ALPRE.PA's P/E ratio is -3.01. In terms of profitability, ALECR.PA's ROE is +0.10%, compared to ALPRE.PA's ROE of +1.10%. Regarding short-term risk, ALECR.PA is less volatile compared to ALPRE.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALECR.PA.

ALECR.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALECR.PA stands at 89.8M. In comparison, EEP.MC has a market cap of 6.3M. Regarding current trading prices, ALECR.PA is priced at €17,800.00, while EEP.MC trades at €0.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALECR.PA currently has a P/E ratio of 12.55, whereas EEP.MC's P/E ratio is -54.00. In terms of profitability, ALECR.PA's ROE is +0.10%, compared to EEP.MC's ROE of N/A. Regarding short-term risk, ALECR.PA is less volatile compared to EEP.MC. This indicates potentially lower risk in terms of short-term price fluctuations for ALECR.PA.

ALECR.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALECR.PA stands at 89.8M. In comparison, MLAHC.PA has a market cap of 5.4M. Regarding current trading prices, ALECR.PA is priced at €17,800.00, while MLAHC.PA trades at €0.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALECR.PA currently has a P/E ratio of 12.55, whereas MLAHC.PA's P/E ratio is -10.00. In terms of profitability, ALECR.PA's ROE is +0.10%, compared to MLAHC.PA's ROE of N/A. Regarding short-term risk, ALECR.PA and MLAHC.PA have similar daily volatility (0.00).

ALECR.PA plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ALECR.PA stands at 89.8M. In comparison, GV.PA has a market cap of 693.2K. Regarding current trading prices, ALECR.PA is priced at €17,800.00, while GV.PA trades at €0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ALECR.PA currently has a P/E ratio of 12.55, whereas GV.PA's P/E ratio is -0.02. In terms of profitability, ALECR.PA's ROE is +0.10%, compared to GV.PA's ROE of -7.61%. Regarding short-term risk, ALECR.PA is less volatile compared to GV.PA. This indicates potentially lower risk in terms of short-term price fluctuations for ALECR.PA.